Kisspeptin

Kisspeptin

Kisspeptin is a KISS1-encoded hypothalamic neuropeptide that acts as the master upstream regulator of the reproductive axis, studied by endocrinologists, reproductive medicine specialists, and men’s health clinicians for its role in HPG axis activation, testosterone support, and reproductive function. Licensed practitioners looking to buy Kisspeptin can contact Medical Spa Rx’s professional support team for guidance on sourcing from qualified suppliers and for access to supporting documentation, including purity information. Browse this page to learn more about Kisspeptin and its research applications through the overview and FAQ section below.

How Kisspeptin Works: KISS1R Mechanism & HPG Axis Regulation

Kisspeptin is an endogenous neuropeptide encoded by the KISS1 gene that binds to KISS1R (GPR54) receptors on hypothalamic GnRH neurons, directly depolarizing them via TRPC channel activation and Kir channel inhibition to stimulate pulsatile GnRH release.[4] This upstream activation drives anterior pituitary secretion of LH and FSH, which in turn supports gonadal hormone synthesis, including testosterone and estrogen. It is evaluated as a sexual health and hormonal peptide for HPG axis activation, testosterone support, and reproductive function research.

Physiological Roles & Upstream Hierarchy

Kisspeptin is widely described as a regulator of reproduction because it gates the onset of puberty, fertility, and reproductive axis activity across sexes. The expression of kisspeptin and GnRH pulsatility patterns differ between males and females, representing a sexual dimorphism with direct relevance to fertility research and the assessment of reproductive function. Because Kisspeptin acts at the hypothalamic level, it sits one step above Gonadorelin in the HPG axis cascade, preserving the full hypothalamic-pituitary signaling chain rather than bypassing the hypothalamus entirely.

Pulsatile Dynamics & Desensitization Risks

Pulsatile administration is mechanistically critical and must be understood before evaluating any Kisspeptin protocol. Continuous exposure causes KISS1R desensitization, which paradoxically suppresses rather than stimulates the HPG axis.[4] This is not a minor caution; sustained flat exposure beyond the acute window can produce the opposite of the intended endocrine effect. Any protocol under consideration must account for pulsatile timing from the outset.

Exploratory Limbic & Reward Circuit Modulation

Kisspeptin also appears to modulate brain activity in limbic and reward circuits relevant to sexual behavior and mood, based on early human imaging and neurophysiological studies. This remains an emerging area with preliminary evidence only and should not be presented as an established indication.

Does Kisspeptin Increase Testosterone?

Kisspeptin indirectly increases testosterone by activating KISS1R on hypothalamic GnRH neurons, stimulating pituitary LH release, and driving Leydig cell testosterone synthesis. Human trial evidence supports this upstream physiological cascade.

Primary Human Infusion Data

• The 22.5-Hour Infusion Study (George et al., 2011): Demonstrated that intravenous Kisspeptin-10 at an infusion rate of approximately 4 mcg/kg/h increased LH from 5.4 to 20.8 IU/L and testosterone from 16.6 to 24.0 nmol/L in healthy men.[1]
• The Dose-Response Study (Dhillo et al., 2005): Documented dose-dependent LH increases and significant testosterone elevation at infusion rates of 0.25-12 pmol/kg/min over 90-minute infusion periods.[2]

The Crucial Temporal Distinction

These published findings reflect acute, short-term stimulation, in which continuous exposure for less than 24 hours successfully produces HPG activation. This is distinct from extended continuous exposure beyond 24-48 hours, which carries a risk of severe receptor desensitization and may paradoxically suppress rather than stimulate the axis. This is consistent with the KISS1R mechanism described above. Both bodies of evidence represent controlled research data rather than approval-level prescribing guidance.

Bounded Research Applications & Neuro-Exploration

• Hypogonadotropic Hypogonadism: Research models support the role of hypothalamic GnRH stimulation in successfully restoring downstream gonadotropin output.[5]
• Testicular Target Uncertainty: While upstream signaling is clear, the direct testicular role of Kisspeptin beyond initiating that hypothalamic signal remains less clearly defined.[5]
• Neural Processing Data: Imperial College research teams have investigated Kisspeptin’s effects on neural responses during sexual brain processing tasks and on penile rigidity assessments in preliminary human studies.

Evidence Calibration Note: The neurological findings are strictly preliminary, confined to specific measured parameters, and should not be generalized to broader claims about mood or sexual function outcomes. The strongest claim supported by current human trial evidence is that Kisspeptin can stimulate LH and, under acute, continuous conditions, testosterone, but it is not approved for any indication.

Proper Dosage of Kisspeptin, Storage & Administration

No approved Kisspeptin dosing protocol exists. Human studies have used intravenous Kisspeptin-10 at infusion rates of approximately 0.25–12 pmol/kg·min (Dhillo et al., 2005)[2] and 4 μg/kg·h (George et al., 2011)[1], with measurable gonadotropin responses documented across both protocols. These values are research references only and should not be treated as prescribing guidance.

Subcutaneous protocols (practitioner-reported) are dose-extrapolated from IV trial data and are not standardized therapy. Kisspeptin dosage for research contexts must be individualized, interpreted through the practitioner’s assessment of the research objective and the individual’s endocrine profile, and approached with specialist review and careful monitoring.

Pulsatile timing is not optional. Sustained flat exposure may produce KISS1R desensitization and HPG axis suppression in preclinical models, consistent with the mechanistic review literature.[4] Human studies support short-term endocrine stimulation, but no universally accepted chronic protocol has been established. Any protocol that aims to approximate physiologic reproductive signaling must account for this from the design stage.

Storage and reconstitution are product-specific. Research-grade Kisspeptin is typically reconstituted with bacteriostatic water and stored at 2–8°C after reconstitution, protected from light. Handling should follow the certificate of analysis and supplier documentation for each batch.

Kisspeptin Side Effects, Safety & Legal Status

Kisspeptin has been generally well-tolerated at research doses in human studies.[1],[2] Transient LH and FSH surges are among the most commonly reported findings, consistent with the compound’s mechanism. Mild injection-site reactions are also reported, consistent with subcutaneous administration. The overall safety database remains limited because most studies are short-duration and involve small numbers of participants. Long-term human safety data are lacking, and this gap should be explicitly acknowledged in any evaluation of research protocols.

The most important safety consideration is desensitization with non-pulsatile exposure. Continuous administration beyond the acute window can suppress rather than stimulate the HPG axis, meaning practitioners and research teams evaluating Kisspeptin protocols must understand and implement pulsatile dosing as a non-negotiable feature.[4]

Current Regulatory Status

As of June 2026, Kisspeptin is not FDA-approved and has no approved therapeutic formulation in the United States. It is also not TGA-approved in Australia, according to publicly available regulatory resources. Under the 2026 WADA Prohibited List, Kisspeptin is prohibited and classified under Class S2.2 (Peptide Hormones and Mimetics), with Kisspeptin and its agonist analogues explicitly named, consistent with its mechanism of HPG axis activation via KISS1R agonism.[3]

Athletes subject to anti-doping rules should treat Kisspeptin as a banned substance and verify current classification with their governing body before any use.

Kisspeptin vs Gonadorelin & Kisspeptin vs Oxytocin

Kisspeptin and Gonadorelin address different levels of the HPG axis, and that structural distinction is the central factor in research protocol design. Kisspeptin acts at the hypothalamic level to stimulate endogenous GnRH release, preserving the full hypothalamic-pituitary signaling cascade.[4] Gonadorelin replaces GnRH directly at the pituitary level, bypassing the hypothalamus entirely. When the research question involves restoring or assessing the integrity of hypothalamic signaling, Kisspeptin offers an upstream intervention point that Gonadorelin cannot provide. When direct pituitary stimulation is the goal and hypothalamic function is not in question, Gonadorelin is the more direct option. The two are not mutually exclusive — some HPG axis evaluation frameworks may consider each at different stages of the cascade. Researchers who choose to buy Gonadorelin for pituitary-level protocol work can access sourcing guidance and documentation support through Medical Spa Rx’s professional support team.

Within the broader sexual health space, Kisspeptin and Oxytocin address fundamentally different research questions. Kisspeptin drives testosterone synthesis and HPG activation via hypothalamic KISS1R agonism and is the more relevant compound when hormonal axis dysregulation, testosterone deficiency, or reproductive function is the focus.[1],[4] Oxytocin targets OXTR signaling to modulate bonding, stress reduction, and anxiety-adjacent aspects of sexual function — a distinct mechanism suited to relational and psychosocial presentations rather than endocrine ones. Researchers who choose to buy Oxytocin for behavioral or psychosocial protocol work can access sourcing guidance and documentation through Medical Spa Rx’s professional support team.

Where Can Practitioners Buy Kisspeptin Online?

Practitioners looking to buy Kisspeptin online should source exclusively from suppliers who provide verifiable purity documentation, LOT number traceability, and a certificate of analysis (COA). Given that Kisspeptin is a research compound with no approved therapeutic formulation, quality verification through supplier documentation is the primary safeguard available to licensed professionals evaluating it for research use.

Kisspeptin is available for purchase by qualified professionals only. Those reviewing wholesale options should confirm COA availability, batch-specific third-party purity testing, and applicable regulatory status in their jurisdiction before placing an order. When buying Kisspeptin online, practitioners should also check for wholesale buying options that align with professional documentation standards and applicable research-use requirements. Medical Spa Rx’s professional support team offers sourcing guidance and documentation support for licensed professionals evaluating qualified suppliers. Contact Medical Spa Rx’s professional support team directly for directions on verified sourcing.

FAQs

1. What is Kisspeptin?

Kisspeptin is a KISS1-encoded endogenous neuropeptide that binds KISS1R (GPR54) on hypothalamic GnRH neurons and stimulates pulsatile GnRH release, driving downstream LH and FSH secretion and supporting reproductive hormone synthesis.[4] It is the master upstream regulator of the reproductive axis and is also known as Metastin (45–54) and KP-10. It remains a research compound with no approved therapeutic formulation as of June 2026.

2. What does Kisspeptin do?

Kisspeptin activates hypothalamic GnRH neurons via KISS1R binding, driving downstream LH and FSH secretion and supporting testosterone and reproductive hormone synthesis.[4] It regulates the onset of puberty, fertility, and sex-specific GnRH pulsatility patterns. Preliminary human studies at Imperial College have also examined neural responses during sexual brain processing tasks and penile rigidity assessments, though these findings remain early-stage.

3. Does Kisspeptin increase testosterone?

Yes, indirectly. Kisspeptin activates KISS1R on hypothalamic GnRH neurons, stimulating pituitary LH release and driving Leydig cell testosterone synthesis. George et al. (J Clin Endocrinol Metab, 2011) demonstrated that IV Kisspeptin-10 at 4 μg/kg·h increased LH from 5.4 to 20.8 IU/L and testosterone from 16.6 to 24.0 nmol/L over approximately 22.5 hours in healthy men.[1]

4. What is the proper dosage of Kisspeptin?

No approved dosing protocol exists. Human studies have used IV Kisspeptin-10 at infusion rates of approximately 0.25–12 pmol/kg·min (Dhillo et al., 2005)[2] and 4 μg/kg·h (George et al., 2011)[1] as research references. Subcutaneous protocols are practitioner-reported and research-extrapolated. Pulsatile timing is mechanistically critical, as continuous use beyond the acute window can suppress rather than stimulate the HPG axis.[4]

5. What are the Kisspeptin side effects?

Kisspeptin is generally well tolerated in short human studies, with transient LH and FSH surges and mild injection-site reactions most often reported.[1],[2] Non-pulsatile exposure beyond the acute window may cause KISS1R desensitization and HPG axis suppression.[4] Long-term human safety data are limited, and this gap should be factored into any protocol evaluation.

6. Is Kisspeptin legal?

Kisspeptin is not FDA-approved or TGA-approved and has no approved therapeutic formulation as of June 2026. Under the 2026 WADA Prohibited List, Kisspeptin is classified under Class S2.2 (Peptide Hormones and Mimetics), with Kisspeptin and its agonist analogues explicitly named as prohibited substances.[3] Athletes subject to anti-doping rules should verify their current classification with their governing body before any use.

7. Where to buy Kisspeptin?

Licensed professionals evaluating Kisspeptin for research purposes should prioritize verified purity documentation, COA availability, and LOT traceability. When buying Kisspeptin online, confirming batch-specific documentation and regulatory status in the relevant jurisdiction is especially important, given its classification as a research compound. Medical Spa Rx’s professional support team can provide sourcing guidance and documentation support for those assessing qualified suppliers.

References

1. George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011;96(8):E1228-E1236. doi:1210/jc.2011-0089
2. Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab. 2005;90(12):6609-6615. doi:10.1210/jc.2005-1468
3. World Anti-Doping Agency. International Standard Prohibited List: 2026 Prohibited List. Published September 2025. https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf
4. Oakley AE, Clifton DK, Steiner RA. Kisspeptin signaling in the brain. Endocr Rev. 2009;30(6):713-743. doi:10.1210/er.2009-0005
5. Sharma A, Thaventhiran T, Minhas S, Dhillo WS, Jayasena CN. Kisspeptin and Testicular Function-Is it Necessary?. Int J Mol Sci. 2020;21(8):2958. Published 2020 Apr 22. doi:10.3390/ijms21082958

The page and all of its displayed contents are for medical professionals, designed to inform only, and not as a replacement for medical advice.